Acutus Medical, Inc.

$0.00-50.00%($-0.00)
TickerSpark Score
62/100
Mixed
73
Valuation
40
Profitability
100
Growth
68
Health
30
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AFIB research report →

52-Week Range0% of range
Low $0.00
Current $0.00
High $0.01

Companywww.acutusmedical.com

Acutus Medical, Inc. , an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. The company's product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs.

CEO
Takeo Mukai
IPO
2020
Employees
85
HQ
Carlsbad, CA, US

Price Chart

-99.68% · this period
$0.03$0.02$0.00May 19Nov 17May 19

Valuation

Market Cap
$2.99K
P/E
-0.00
P/S
0.00
P/B
-0.00
EV/EBITDA
9.67
Div Yield
0.00%

Profitability

Gross Margin
5.03%
Op Margin
-0.28%
Net Margin
-47.36%
ROE
153.11%
ROIC
-0.24%

Growth & Income

Revenue
$20.16M · 181.37%
Net Income
$-9,547,000 · 88.31%
EPS
$-0.32 · 88.61%
Op Income
$-57,000
FCF YoY
49.84%

Performance & Tape

52W High
$0.01
52W Low
$0.00
50D MA
$0.00
200D MA
$0.00
Beta
6.14
Avg Volume
2.35K

Get TickerSpark's AI analysis on AFIB

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
Jan 27, 25Flynn James Esell1,889,509
Jan 27, 25Flynn James Esell31,116
Jan 27, 25Flynn James Esell209,996
Mar 1, 24Mukai Takeoother8,475
Feb 6, 24Sohn Tomother7,582
Feb 1, 24Mukai Takeoother2,869
Feb 1, 24Sohn Tomother5,709
Jan 7, 24Mathews Kevinother6,342
Jan 7, 24Roman Davidother24,086
Sep 1, 23Mukai Takeoother1,729

Our AFIB Coverage

We haven't published any research on AFIB yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate AFIB Report →

Similar Companies